COLGATE-PALMOLIVE (INDIA) LTD. - 500830 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg.74(5) of SEBI (DP) Regulations, 201814-06-2022
14-06-2022
COLGATE-PALMOLIVE (INDIA) LTD. - 500830 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Loss of Certificate/Duplicate Certificate13-06-2022
Market movers: LIC hits all time low of Rs 800; strict stance of govt on saccharin leaves bitter taste for some
Colgate Palmolive ended down 1.66 per cent, while Procter & Gamble Hygiene & Health Care were down over 2 per cent.03-06-2022
COLGATE-PALMOLIVE (INDIA) LTD. - 500830 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Investors'' call- Transcript02-06-2022
Higher volume growth trajectory key for reversal of Colgate's fortunes
The company is relying on relaunches, foraying into new segments, digital strategy to address growth issues31-05-2022
COLGATE-PALMOLIVE (INDIA) LTD. - 500830 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst/Institutional Investor Meetings.30-05-2022
Accumulate Colgate Palmolive; target of Rs 1708: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Colgate Palmolive with a target price of Rs 1708 in its research report dated May 26, 2022.27-05-2022
Colgate's outlook remains subdued
Colgate has a strong pipeline of product launches and re-launches. This would mean increased advertising costs to support the same. As such, it remains to be seen if such launches would help boost its revenue. Also, investors would closely track the strategic changes under new CEO27-05-2022
COLGATE-PALMOLIVE (INDIA) LTD. - 500830 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Loss of Certificate / Duplicate Certificate26-05-2022
COLGATE-PALMOLIVE (INDIA) LTD. - 500830 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Presentation on Investors'' conference call26-05-2022